Key Takeaways
- • Warburg Pincus and Lendlease's jointly established platform, operating through managed investment vehicle LINO, acquired a S$1.6 billion portfolio of industrial and life sciences assets in Singapore from Blackstone-associated entities and Lim Chap Huat (Executive Chairman of Soilbuild Group Holdings), representing one of the largest private industrial asset transactions in Singapore's market.
- • The portfolio spans 4.5 million square feet of gross floor area comprising high-quality business parks and specialist facilities across established designated precincts, tenant-occupied by blue-chip companies in life sciences, technology, advanced manufacturing, and logistics sectors.
- • This acquisition marks the first transaction for the JV platform since its official launch on 31 July 2024, immediately establishing the platform as market-leading in Asia Pacific life sciences and R&D real estate with over S$2 billion in assets under management.
- • The deal reinforces Warburg Pincus and Lendlease's strategic positioning in the rapidly expanding Asia Pacific life sciences and R&D real estate sector, with both firms citing the tightly held Singapore market and region's growth trajectory as key conviction drivers.
Summary
The Warburg Pincus-Lendlease joint venture platform announced on 27 August 2024 the acquisition of a S$1.6 billion portfolio of industrial and life sciences assets in Singapore, marking the platform's inaugural transaction since launching on 31 July 2024. The deal was executed through LINO, the platform's managed investment vehicle, and involved the purchase of assets from entities associated with Blackstone and Lim Chap Huat, Executive Chairman of Soilbuild Group Holdings Ltd. According to the announcement, this transaction represents one of the largest private industrial asset sales in Singapore's market.
The portfolio comprises 4.5 million square feet of gross floor area distributed across high-quality business parks and specialist facilities positioned within established designated precincts throughout Singapore. Tenant occupancy spans blue-chip companies operating in life sciences, technology, advanced manufacturing, and logistics—sectors experiencing substantial growth in the Asia Pacific region. The strategic selection of asset types aligns directly with the JV platform's stated focus on life sciences and R&D real estate.
With this acquisition, the Warburg Pincus-Lendlease platform has achieved immediate scale in Singapore's tightly held market, securing over S$2 billion in assets under management. Takashi Murata, Managing Director and Co-Head of Asia Real Estate at Warburg Pincus, characterized the acquisition as "a landmark transaction," emphasizing that it solidifies the partnership's position as "one of the top industrial asset owners in Singapore" and reflects conviction in the life sciences and R&D sector's trajectory. Justin Gabbani, CEO of Investment Management at Lendlease, reinforced the strategic rationale, noting that the acquisition underscores both firms' commitment to the "rapidly expanding life sciences and R&D real estate market in Asia Pacific."
The timing and scale of this first platform transaction underscore the partnerships' intent to capitalize on structural tailwinds in Asia Pacific's specialized real estate market, where life sciences and R&D facilities continue to attract significant institutional capital and tenant demand.
The portfolio comprises 4.5 million square feet of gross floor area distributed across high-quality business parks and specialist facilities positioned within established designated precincts throughout Singapore. Tenant occupancy spans blue-chip companies operating in life sciences, technology, advanced manufacturing, and logistics—sectors experiencing substantial growth in the Asia Pacific region. The strategic selection of asset types aligns directly with the JV platform's stated focus on life sciences and R&D real estate.
With this acquisition, the Warburg Pincus-Lendlease platform has achieved immediate scale in Singapore's tightly held market, securing over S$2 billion in assets under management. Takashi Murata, Managing Director and Co-Head of Asia Real Estate at Warburg Pincus, characterized the acquisition as "a landmark transaction," emphasizing that it solidifies the partnership's position as "one of the top industrial asset owners in Singapore" and reflects conviction in the life sciences and R&D sector's trajectory. Justin Gabbani, CEO of Investment Management at Lendlease, reinforced the strategic rationale, noting that the acquisition underscores both firms' commitment to the "rapidly expanding life sciences and R&D real estate market in Asia Pacific."
The timing and scale of this first platform transaction underscore the partnerships' intent to capitalize on structural tailwinds in Asia Pacific's specialized real estate market, where life sciences and R&D facilities continue to attract significant institutional capital and tenant demand.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.